Insulin resistance and heart failure with preserved ejection fraction. Pathogenetic and therapeutic crossroads
Insulin resistance, which is a fundamental pathogenetic factor of prediabetes, is closely associated with abdominal obesity on the one hand and the development of cardiovascular diseases, heart failure (HF), on the other. The pathogenetic role of insulin resistance is multifaceted and consists in th...
Saved in:
| Main Authors: | O. V. Tsygankova, N. E. Evdokimova, V. V. Veretyuk, L. D. Latyntseva, A. S. Ametov |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Endocrinology Research Centre
2023-01-01
|
| Series: | Сахарный диабет |
| Subjects: | |
| Online Access: | https://www.dia-endojournals.ru/jour/article/view/12916 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effect of extended-release metformin on humoral cardiometabolic markers and lipid peroxidation parameters in patients with prediabetes, heart failure with preserved ejection fraction and abdominal obesity
by: O. V. Tsygankova, et al.
Published: (2024-08-01) -
Phenotypic clusters in heart failure with preserved and mid-range ejection fraction: new data and perspectives
by: O. V. Tsygankova, et al.
Published: (2021-05-01) -
Extended-release metformin in patients with prediabetes, chronic heart failure and abdominal obesity in light of the effect on fat depot compartments and glucose metabolism parameters
by: O. V. Tsygankova, et al.
Published: (2024-09-01) -
Comparison of the effects of metformin and empagliflozin on cardiac function in heart failure with preserved ejection fraction mice
by: Xiehong Liu, et al.
Published: (2025-04-01) -
Features of phenotyping patients with heart failure with preserved ejection fraction
by: E. K. Serezhina, et al.
Published: (2023-09-01)